Fibromyalgia (FM) is a painful syndrome with a generalized and chronic characteristic in the musculoskeletal system, but not articular. It is present on average from 2 to 5% of the world population. It is predominant in the female gender, with 10 individuals, from 7 to 9 being women, with a higher prevalence between 35 to 45 years of age 1,2. The origin of the syndrome is still unknown and the diagnosis must be made clinically, as there are no laboratory and imaging tests for FM. In addition to the exacerbated painful aspect (hyperalgesia), other symptoms are associated, such as, intense fatigue, non-restorative sleep, mood disorders (anxiety and depression), cognitive changes (attention and memory), irritable bowel syndrome, paraesthesia, feeling of edema, among others, consequently, generates disabilities and leads to psychosomatic and psychosocial changes3,4.
|